Skip to content
10-Q

Quarterly Report

ANTIVIRAL TECHNOLOGIES, INC.

0001137050-13-000349

← back to feed
Filed
Nov 13, 2013 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2013 · Nov 12, 2013 14.84M sh
Operating Cash Flow Q3 2013 · Sep 30, 2013 −$1.24M
Operating Cash Flow Q3 2013 · Sep 30, 2012 −$76.1K
Stockholders Equity Q3 2013 · Sep 30, 2013 −$2.57M
Stockholders Equity Q3 2013 · Dec 31, 2012 −$2.3M
Total Liabilities Q3 2013 · Sep 30, 2013 $3.05M
Total Liabilities Q3 2013 · Dec 31, 2012 $2.79M
Current Assets Q3 2013 · Sep 30, 2013 $643
Current Assets Q3 2013 · Dec 31, 2012 $701
Total Assets Q3 2013 · Sep 30, 2013 $485.94K
Total Assets Q3 2013 · Dec 31, 2012 $485.2K
Sga Expense Q3 2013 · Sep 30, 2013 $2.39M
Sga Expense Q3 2013 · Sep 30, 2012 $76.79K
Sga Expense Q3 2013 · Sep 30, 2012 $240.57K
Net Income Q3 2013 · Sep 30, 2013 −$2.56M
Net Income Q3 2013 · Sep 30, 2012 −$77.05K
Net Income Q3 2013 · Sep 30, 2012 −$247.41K
Cash And Equivalents Q3 2013 · Sep 30, 2012 $382
Cash And Equivalents Q3 2013 · Dec 31, 2011 $3.94K